No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Chemicals - Specialty
Fufeng Group Limited, an investment holding company, specializes in the global production and distribution of fermentation-based food additives, biochemicals, and starch-derived products, operating across markets in the People's Republic of China and internationally. Its business is structured into several key segments: Food Additives, Animal Nutrition, High-End Amino Acid, Colloid, and an encompassing 'Other' segment. The Food Additives division is responsible for manufacturing and selling items such as monosodium glutamate (MSG), starch sweeteners, glutamic acid, compound seasonings, and corn oil. The Animal Nutrition segment focuses on producing and selling refined corn products, threonine, and lysine. High-end amino acids are offered through its dedicated segment, while the Colloid segment provides specialty gums like xanthan and gellan gum. The 'Other' segment encompasses a diverse range of products, including fertilizers, synthetic ammonia, and pharmaceuticals. Beyond these core activities, Fufeng Group is also engaged in the manufacturing and sale of construction materials such as autoclaved aerated concrete blocks and bricks, alongside eubacteria material medicine and various preparations. The company actively invests in the research, development, promotion, and industrialization of innovative biological techniques and their resultant achievements. Furthermore, it deals in cosmetics, biological products, and health foods, while also offering logistics, equity investment, and biological technique information services. Fufeng Group Limited was founded in 1999 and is headquartered in Linyi, People's Republic of China.
www.fufeng-group.comNo one on the platform currently holds 0546.HK.
No tracked institution reports a position in 0546.HK as of their last filing.
No one on the platform has traded 0546.HK yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 12.2% | 14.8% | 12.4% | — | — | — |
| Rev. Growth % | 0.4% | 10.8% | ||||
| Profit Margin % | 8.8% | 9.7% | 9.2% | |||
| Free Cash Flow Margin % | 0.9% | 5.0% | 1.5% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $32.8B | +7.2% | $0.49 | $0.42–$0.55 | — | 4 |
| 2027 | $34.7B | +5.9% | $0.77 | $0.67–$0.84 | — | 4 |
| 2028 | $36.7B | +5.8% | $0.98 | $0.95–$1.01 | — | 2 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| $0.11 |
| +0.00% |
| $80M |
| — |
| 2009.HKBBMG Corporation | $0.61 | +2.52% | $12.4B | — |
| 2233.HKWest China Cement Limited | $1.81 | -0.55% | $9.9B | — |
Source: Financial Modeling Prep · peers by sector/industry